Chiarot, Emiliano
Spagnuolo, Angela
Maccari, Silvia
Naimo, Eleonora
Acquaviva, Alessandra
Cecchi, Raffaella
Galletti, Bruno
Fabbrini, Monica
Mori, Elena
Ruggiero, Paolo
Grandi, Guido
Fontana, Maria Rita
Bensi, Giuliano
Margarit, Immaculada
Article History
Received: 16 October 2017
Accepted: 18 January 2018
First Online: 7 February 2018
Competing Interests
: This work was sponsored by Novartis Vaccines and Diagnostics Srl, now acquired by the GSK group of companies. All authors have declared the following interests: all authors were employees of Novartis Vaccines at the time of the study. Following the acquisition of Novartis Vaccines by the GSK group of companies in March, 2015, all authors except EN, AA, PR, MRF and GG are employees of GSK Vaccines. GB and IMR report ownership of GSK shares and/or restricted GSK shares. EC, BG, EM, PR, MRF, GG, GB and IMR are listed as inventors on patents owned by the GSK group of companies.